SCHEMBL26242512

SCHEMBL26242512

Cc1nnc(-c2ccc(F)cc2)c(C)c1C

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 3/20 0.44
ADORA1 P30542 3/20 0.44
ADORA2B P29275 2/20 0.44
MAPK14 Q16539 9/20 0.43
CACNA2D1 P54289 1/20 0.41
MAPK10 P53779 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
MAPK13 O15264 5/20 0.38
MAPK12 P53778 5/20 0.38
MAPK11 Q15759 5/20 0.38
CSNK1D P48730 1/20 0.38
CSNK1E P49674 1/20 0.38
GCGR P47871 1/20 0.37
ACHE P22303 1/20 0.37
PTGS2 P35354 1/20 0.37
RAF1 P04049 1/20 0.36
MAPK9 P45984 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26242506 0.83 CNR1 (0.45) CACNA2D1
SCHEMBL15038352 0.80 ADORA2A (0.49) ADORA2AADORA1ADORA2BMAPK14RAB9A
SCHEMBL26242510 0.79 SMO (0.34) ADORA2AADORA1
SCHEMBL26242537 0.78 MAPT (0.43) MAPK14MAPK13MAPK12MAPK11CSNK1D
SCHEMBL26242505 0.78 MAOB (0.44) ADORA2AADORA1ADORA2BMAPK14NPC1
SCHEMBL26242509 0.77 ADORA2A (0.50) ADORA2AADORA1ADORA2BMAPK14MAPK13
SCHEMBL26246652 0.76 KMT2A (0.54) ADORA1CACNA2D1NPC1RAB9APTGS2
SCHEMBL30617006 0.75 MAPK14 (0.41) ADORA2AADORA1ADORA2BMAPK14NPC1
SCHEMBL1262220 0.74 KMT2A (0.33) NPC1RAB9A
SCHEMBL26242514 0.73 SLC34A1 (0.36) MAPK14CACNA2D1CSNK1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023150201-A2 SODIUM CHANNEL BLOCKING COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE LATIGO BIOTHERAPEUTICS, INC. (US) 2023-08-10 WO disclosed